Pulmonx Corporation (LUNG) Tops Q1 EPS by 7c, provides guidance

Pulmonx Corporation (NASDAQ: LUNG) reported Q1 EPS of ($0.36), $0.07 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $18.9 million versus the consensus estimate of $17.79 million.

GUIDANCE:

Pulmonx Corporation sees Q2 2024 revenue of $81-84 million, versus the consensus of $82.18 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary